We are live on ! Find out more
BOLD

Audentes Therapeutics, Inc
BOLD

Delisted

BOLD was delisted on the 14th of January, 2020.

Back to rankings

57 hedge funds and large institutions have $283M invested in Audentes Therapeutics, Inc in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 5

16% more funds holding

Funds holding: 49 → 57 (+8)

4% more capital invested

Capital invested by funds: $272M → $283M (+$10.8M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

Holders
57
Holders Change
+8
Holders Change %
+16.33%
% of All Funds
1.43%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
13
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$5.61M
2
Millennium Management
Millennium Management
New York
+$1.52M
3
Northern Trust
Northern Trust
Illinois
+$833K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$557K
5
BIT
BlackRock Institutional Trust
California
+$499K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$3.02M
2
SFM
Sphera Funds Management
Israel
-$2.67M
3
RG
Redmile Group
California
-$1.45M
4
OA
Omega Advisors
New York
-$816K
5
PPA
Parametric Portfolio Associates
Washington
-$708K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$782K +$494K +28,600 +201%
BIT
27
BlackRock Institutional Trust
California
$677K +$499K +28,876 +353%
BlackRock
28
BlackRock
New York
$537K +$3.7K +214 +0.7%
Victory Capital Management
29
Victory Capital Management
Texas
$528K -$123K -7,110 -20%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$366K -$222K -12,862 -39%
RI
31
RTW Investments
New York
$365K – – –
Bank of America
32
Bank of America
North Carolina
$348K -$17.6K -1,017 -5%
Goldman Sachs
33
Goldman Sachs
New York
$342K +$105K +6,099 +48%
PPA
34
Parametric Portfolio Associates
Washington
$319K -$708K -40,966 -70%
BIM
35
BlackRock Investment Management
Delaware
$318K +$55K +3,184 +22%
Morgan Stanley
36
Morgan Stanley
New York
$305K +$289K +16,717 New
ProShare Advisors
37
ProShare Advisors
Maryland
$279K +$264K +15,277 New
VM
38
VHCP Management
New York
$274K – – –
Bank of New York Mellon
39
Bank of New York Mellon
New York
$253K +$239K +13,834 New
TCIM
40
TIAA CREF Investment Management
New York
$217K +$205K +11,866 New
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$216K -$6.91K -400 -3%
Charles Schwab
42
Charles Schwab
California
$196K +$185K +10,700 New
TD Asset Management
43
TD Asset Management
Ontario, Canada
$194K -$1.73K -100 -0.9%
SG Americas Securities
44
SG Americas Securities
New York
$138K +$131K +7,569 New
PA
45
Perceptive Advisors
New York
$137K – – –
TA
46
Teachers Advisors
New York
$111K – – –
Deutsche Bank
47
Deutsche Bank
Germany
$71K +$52.6K +3,045 +317%
Wells Fargo
48
Wells Fargo
California
$37K +$35.4K +2,047 New
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$35K +$32.8K +1,900 New
SO
50
STRS Ohio
Ohio
$32K – – –
1
2
3

BOLD Hedge Fund Activity: Q4 2016 in Review

57 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Audentes Therapeutics, Inc (BOLD) for Q4 2016, worth a combined $283M — up 4% from $272M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new BOLD positions and 5 closed out — a net gain of 8 holders — while 13 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $5.61M. The largest seller was RA Capital Management, cutting an estimated $3.02M.

  • 57 institutional investors held Audentes Therapeutics, Inc (BOLD) as of Q4 2016, up from 49 in Q3 2016.
  • Funds reported $283M of Audentes Therapeutics, Inc stock for Q4 2016, up 4% quarter-over-quarter.
  • 13 funds opened new Audentes Therapeutics, Inc positions in Q4 2016 and 5 closed out, a net change of +8 holders.
  • The largest Audentes Therapeutics, Inc buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $5.61M added.
  • The largest Audentes Therapeutics, Inc seller in Q4 2016 was RA Capital Management, an estimated $3.02M sold.

Based on aggregated 13F filings for Q4 2016.